NCT06765603View on ClinicalTrials.gov

Evaluating the Efficacy of the Combination of Multi-zonal Contact Lens and Atropine for Controlling Myopia Progression

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions

Myopia

Interventions

DRUG

Atropine 0.025%

Atropine 0.025%

DEVICE

Multizonal contact lens

Multizonal CL

DRUG

Placebo

Placebo

DEVICE

Single vision Contact lens

Single vision contact lens

All Listed Sponsors

lead

Singapore National Eye Centre

OTHER_GOV